HLA Genetic Polymorphisms and Prognosis of Patients with COVID-19

Overview

Journal Med Intensiva

Specialty Critical Care

Date 2024 Apr 15

PMID 38620408

Authors

L Lorente

M M Martin

A Franco

Y Barrios

J J Caceres

J Sole-Violan

A Perez

J A Marcos Y Ramos

L Ramos-Gomez

N Ojeda

A Jimenez

Affiliations

Soon will be listed here.

Abstract

Objective: Different genetic polymorphisms of human leukocyte antigen (HLA) have been associated with the risk and prognosis of autoimmune and infectious diseases. The objectives of this study were to determine whether there is an association between HLA genetic polymorphisms and the susceptibility to and mortality of coronavirus disease 2019 (COVID-19) patients.

Design: Observational and prospective study.

Setting: Eight Intensive Care Units (ICU) from 6 hospitals of Canary Islands (Spain).

Patients: COVID-19 patients admitted in ICU and healthy subjects.

Interventions: Determination of HLA genetic polymorphisms.

Main Variable Of Interest: Mortality at 30 days.

Results: A total of 3886 healthy controls and 72 COVID-19 patients (10 non-survivors and 62 survivor patients at 30 days) were included. We found a trend to a higher rate of the alleles HLA-A*32 ( = 0.004) in healthy controls than in COVID-19 patients, and of the alleles HLA-B*39 ( = 0.02) and HLA-C*16 ( = 0.02) in COVID-19 patients than in healthy controls; however, all these p-values were not significant after correction for multiple comparisons. Logistic regression analysis showed that the presence of certain alleles was associated with higher mortality, such as the allele HLA-A*11 after controlling for SOFA (OR = 7.693; 95% CI = 1.063-55.650; = 0.04) or APACHE-II (OR = 11.858; 95% CI = 1.524-92.273; = 0.02), the allele HLA-C*01 after controlling for SOFA (OR = 11.182; 95% CI = 1.053-118.700; = 0.04) or APACHE-II (OR = 17.604; 95% CI = 1.629-190.211; = 0.02), and the allele HLA-DQB1*04 after controlling for SOFA (OR = 9.963; 95% CI = 1.235-80.358; = 0.03).

Conclusions: The new finding from our preliminary study of small sample size was that HLA genetic polymorphisms could be associated with COVID-19 mortality; however, studies with a larger sample size before definitive conclusions can be drawn.

Citing Articles

Rare peptide anchors of HLA class I alleles contribute to the COVID-19 disease severity and T cell memory.

Wang X, Zhang J, Guo P, Guo Y, Yang X, Liu M Biosaf Health. 2025; 5(6):355-362.

PMID: 40078747 PMC: 11895035. DOI: 10.1016/j.bsheal.2023.09.002.

Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity.

Mazzotti L, Borges de Souza P, Azzali I, Angeli D, Nanni O, Sambri V HLA. 2025; 105(1):e70011.

PMID: 39807702 PMC: 11731316. DOI: 10.1111/tan.70011.

Associations Between Clinical Manifestations of SARS-CoV-2 Infection and HLA Alleles in a Caucasian Population: A Molecular HLA Typing Study.

Tymoniuk B, Borowiec M, Makowska J, Holwek E, Sarnik J, Styrzynski F J Clin Med. 2025; 13(24.

PMID: 39768617 PMC: 11676434. DOI: 10.3390/jcm13247695.

The role of inflammatory gene polymorphisms in severe COVID-19: a review.

Yip J, Oo A, Ng Y, Chin K, Tan K, Chu J Virol J. 2024; 21(1):327.

PMID: 39707400 PMC: 11662554. DOI: 10.1186/s12985-024-02597-3.

The molecular mechanisms of CD8 T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions.

Deng S, Xu Z, Hu J, Yang Y, Zhu F, Liu Z Front Immunol. 2024; 15:1468456.

PMID: 39450171 PMC: 11499136. DOI: 10.3389/fimmu.2024.1468456.

References

Knoring B, Berkos A, Sakharova I . [Distribution of histocompatibility antigens in patients with pulmonary tuberculosis depending on disease course and immune response pattern]. Probl Tuberk. 1995; (2):16-9. View

Lorente L, Martin M, Abreu-Gonzalez P, Ramos L, Argueso M, Caceres J . Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury. J Neurotrauma. 2014; 32(1):1-6. PMC: 4273195. DOI: 10.1089/neu.2014.3456. View

Strock S, Gaudieri S, Mallal S, Yu C, Mitchell D, Cogan J . Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 - a case control study. BMC Infect Dis. 2015; 15:206. PMC: 4424560. DOI: 10.1186/s12879-015-0943-7. View

Mosaad Y, Farag R, Arafa M, Eletreby S, El-Alfy H, Eldeek B . Association of human leucocyte antigen Class I (HLA-A and HLA-B) with chronic hepatitis C virus infection in Egyptian patients. Scand J Immunol. 2010; 72(6):548-53. DOI: 10.1111/j.1365-3083.2010.02468.x. View

Koziel M, Dudley D, Afdhal N, Grakoui A, Rice C, Choo Q . HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest. 1995; 96(5):2311-21. PMC: 185882. DOI: 10.1172/JCI118287. View

Keicho N, Hijikata M . Genetic predisposition to diffuse panbronchiolitis. Respirology. 2011; 16(4):581-8. DOI: 10.1111/j.1440-1843.2011.01946.x. View

Lorente L, Martin M, Perez-Cejas A, Gonzalez-Rivero A, Argueso M, Ramos L . Serum caspase-3 levels during the first week of traumatic brain injury. Med Intensiva (Engl Ed). 2019; 45(3):131-137. DOI: 10.1016/j.medin.2019.09.005. View

Dutta M, Dutta P, Medhi S, Borkakoty B, Biswas D . Polymorphism of HLA class I and class II alleles in influenza A(H1N1)pdm09 virus infected population of Assam, Northeast India. J Med Virol. 2018; 90(5):854-860. DOI: 10.1002/jmv.25018. View

Cruz-Robles D, Reyes P, Monteon-Padilla V, Ortiz-Muniz A, Vargas-Alarcon G . MHC class I and class II genes in Mexican patients with Chagas disease. Hum Immunol. 2004; 65(1):60-5. DOI: 10.1016/j.humimm.2003.10.008. View

10.

Serrano-Martinez J, Machado-Casas J, Redondo-Orts M, Manzano-Manzano F, Castano-Perez J, Perez-Villares J . [Characteristics and results of a series of 59 patients with severe pneumonia due to COVID-19 admitted in the ICU]. Med Intensiva (Engl Ed). 2020; 44(9):580-583. PMC: 7298456. DOI: 10.1016/j.medin.2020.06.004. View

11.

Lai M, Hsu C, Lin C, Chien R, Lin W, Chang C . Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study. Hepatol Int. 2018; 12(5):456-464. DOI: 10.1007/s12072-018-9890-x. View

12.

Wang W, Zhang W, Zhang J, He J, Zhu F . Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19). HLA. 2020; 96(2):194-196. PMC: 7276866. DOI: 10.1111/tan.13941. View

13.

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S . Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7):934-943. PMC: 7070509. DOI: 10.1001/jamainternmed.2020.0994. View

14.

Ou G, Xu H, Yu H, Liu X, Yang L, Ji X . The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection. J Transl Med. 2018; 16(1):362. PMC: 6299522. DOI: 10.1186/s12967-018-1716-z. View

15.

Holub M, Hobstova J, Prazak J, Pudil P . [Association of class I HLA antigens with invasive meningococcal disease]. Cas Lek Cesk. 1998; 137(19):598-600. View

16.

Tuttolomondo A, Colomba C, Di Bona D, Casuccio A, Di Raimondo D, Clemente G . HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis. Oncotarget. 2018; 9(25):17523-17532. PMC: 5915134. DOI: 10.18632/oncotarget.24778. View

17.

Chalub S, da Silva R, da Silva A, de Aquino P, Sadahiro A, Kalil A . Evaluation of a histocompatibility antigen related to hepatitis B virus in patients with hepatocellular carcinoma in the western Brazilian Amazon. Genet Mol Res. 2013; 12(2):1336-46. DOI: 10.4238/2013.April.25.5. View

18.

Zhao J, Wang L, Lin H, Yu W, Xu X, Hu H . Association of HLA-DRB1/DQB1 polymorphism with high-risk HPV infection and cervical intraepithelial neoplasia women from Shanghai. Int J Clin Exp Pathol. 2020; 11(2):748-756. PMC: 6958010. View

19.

Muniz-Castrillo S, Vogrig A, Honnorat J . Associations between HLA and autoimmune neurological diseases with autoantibodies. Auto Immun Highlights. 2020; 11(1):2. PMC: 7065322. DOI: 10.1186/s13317-019-0124-6. View

20.

Carrasco G, Morillas J, Calizaya M, Baeza I, Molina R, Meije Y . [ICU decision making based on Living Systematic Review strategy during SARS-CoV-2 pandemic. Results of a prospective case serie]. Med Intensiva (Engl Ed). 2020; 44(8):516-519. PMC: 7287417. DOI: 10.1016/j.medin.2020.06.001. View